title: Peroxynitrite-mediated inhibition of DOPA synthesis in PC12 cells.
abstract: Experimental evidence has implicated oxidative stress in the development of Parkinson's disease, amyotrophic lateral sclerosis, and other degenerative neuronal disorders. Recently, peroxynitrite, which is formed by the nearly diffusion-limited reaction of nitric oxide with superoxide, has been suggested to be a mediator of oxidant-induced cellular injury. The potential role of peroxynitrite in the pathology associated with Parkinson's disease was evaluated by examining its effect on DOPA synthesis in PC12 pheochromocytoma cells. Peroxynitrite was generated from the compound 3-morpholinosydnonimine (SIN-1), which releases superoxide and nitric oxide simultaneously. Exposure of PC12 cells to peroxynitrite for 60 min greatly diminished their ability to synthesize DOPA without apparent cell death. The inhibition was due neither to the formation of free nitrotyrosine nor the oxidation of DOPA by peroxynitrite. The inhibition in DOPA synthesis by SIN-1 was abolished when superoxide was scavenged by the addition of superoxide dismutase. These data indicated that neither nitric oxide nor hydrogen peroxide generated by the dismutation of superoxide is responsible for the SIN-1-mediated inhibition of DOPA production. The inhibition of DOPA synthesis at high concentration of SIN-1 persisted even after removal of SIN-1. The inactivation of the tyrosine hydroxylase may be responsible for the significant decline in DOPA formation by peroxynitrite. Inactivation of tyrosine hydroxylase may be part of the initial insult in oxidative damage that eventually leads to cell death.
authors.affiliation: Institute for Environmental Medicine, University of Pennsylvania, School of Medicine, Philadelphia, USA.
authors.forename: H
authors.initials: H
authors.lastname: Ischiropoulos
authors.forename: D
authors.initials: D
authors.lastname: Duran
authors.forename: J
authors.initials: J
authors.lastname: Horwitz
mesh_terms: D000818:Animals; D004295:Dihydroxyphenylalanine / Q000037:antagonists & inhibitors* / Q000378:metabolism; D008981:Molsidomine / Q000031:analogs & derivatives / Q000378:metabolism; D009566:Nitrates / Q000502:physiology*; D010084:Oxidation-Reduction / Q000187:drug effects; D016716:PC12 Cells; D051381:Rats; D014443:Tyrosine / Q000031:analogs & derivatives / Q000494:pharmacology
chemical_list: D009566:Nitrates; C039642:peroxynitric acid; C002744:3-nitrotyrosine; D014443:Tyrosine; C002385:linsidomine; D004295:Dihydroxyphenylalanine; D008981:Molsidomine